BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Neovasc Inc. 

13700 Mayfield Place
Suite 2135
Richmond  British Columbia  V6V 2E4  Canada
Phone: 604-270-4344 Fax: 604-270-4384


SEARCH JOBS




Industry
Medical Device

Segment
Equipment





 Company News
Cosira Study Data Presented At American College of Cardiology 14 Confirms The Neovasc Inc. (NVC) Reducer™ Improves Functional Capabilities In Refractory Angina Patients 3/31/2014 9:58:12 AM    More...
Neovasc Inc. (NVC) Reducer™ For Refractory Angina Featured In Live Case Session At 10th Annual Congress Of Update In Cardiology And Cardiovascular Surgery 3/17/2014 11:05:05 AM    More...
Neovasc Inc. (NVC) Announces Successful First Human Implant Of Tiara™ Transcatheter Mitral Valve 2/3/2014 11:52:41 AM    More...
Neovasc Inc. (NVC) Receives First U.S. Patent For Its Novel Tiara™ Transcatheter Mitral Valve Replacement Technology 11/13/2013 11:10:02 AM    More...
Neovasc Inc. (NVC), an OPKO Supported Company, Reports That Reducer™ Achieves Primary Endpoint in COSIRA Trial, Significantly Improving Function in Patients with Refractory Angina 11/7/2013 7:30:31 AM    More...
Neovasc Inc. (NVC) Reducer™ Achieves Primary Endpoint in COSIRA Trial, Significantly Improving Functional Capabilities in Patients With Refractory Angina 11/6/2013 7:08:44 AM    More...
Neovasc Inc. (NVC) Announces Publication of Positive Tiara™ Preclinical Data in the Journal JACC: Cardiovascular Interventions 10/29/2013 11:42:02 AM    More...
Neovasc Inc. (NVC) Announces Upcoming Presentations at TCT 2013 Scientific Symposium 10/24/2013 6:40:22 AM    More...
Neovasc Inc. (NVC) Reports Financial Results For Second Quarter of 2013 8/15/2013 6:21:52 AM    More...
Neovasc Inc. (NVC) Reports Financial Results for First Quarter of 2013 5/28/2013 7:18:09 AM    More...
12345678